Gevo director Amorelli to step down at 2026 meeting

Gevo, Inc. reported that director Angelo Amorelli has informed the Board that he will not stand for re-election at the company’s 2026 Annual Meeting of Stockholders.

Rhea-AI Filing Summary

Gevo, Inc. reported that director Angelo Amorelli has informed the Board that he will not stand for re-election at the company’s 2026 Annual Meeting of Stockholders. He will continue to serve as a director until his current term expires at the Annual Meeting.

The company stated that Dr. Amorelli’s decision is for personal reasons and not due to any disagreement with Gevo regarding its operations, policies, or practices. Gevo expressed its appreciation for his dedicated service and contributions to the Board and the company.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Gevo (GEVO) disclose on March 11, 2026?

Gevo disclosed that director Angelo Amorelli will not stand for re-election at the 2026 Annual Meeting of Stockholders. He will continue serving on the Board until his current term expires at that meeting, ensuring continuity during the transition period.

Why is Gevo (GEVO) director Angelo Amorelli not standing for re-election?

Gevo stated that Angelo Amorelli’s decision not to stand for re-election is for personal reasons. The company specifically noted that his decision was not due to any disagreement regarding Gevo’s operations, policies, or practices during his tenure on the Board.

How long will Angelo Amorelli remain on Gevo’s (GEVO) Board?

Angelo Amorelli will remain a member of Gevo’s Board until his current term ends at the 2026 Annual Meeting of Stockholders. This allows him to continue participating in Board activities up to the conclusion of that meeting.

Did Gevo (GEVO) report any disagreements related to Angelo Amorelli’s departure?

Gevo reported that Angelo Amorelli’s decision not to stand for re-election was not the result of any disagreement with the company. This includes no disagreements regarding its operations, corporate policies, or business practices as a director.

How did Gevo (GEVO) characterize Angelo Amorelli’s service on the Board?

Gevo thanked Angelo Amorelli for his dedicated service and valuable contributions to both the Board and the company. The filing reflects an orderly transition and expresses appreciation rather than indicating any conflict or performance concern.

What type of SEC filing did Gevo (GEVO) use to report the board change?

Gevo used a Form 8-K to report Angelo Amorelli’s decision not to stand for re-election as a director. Form 8-K is commonly used to disclose significant corporate events, including changes in the composition of a company’s Board of Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:02 PM Learn about SEC filing dates

false 0001392380 0001392380 2026-03-11 2026-03-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 11, 2026

Gevo, Inc.

(Exact name of registrant as specified in its charter)

Delaware	001-35073	87-0747704
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)

345 Inverness Drive South, Building C, Suite 310
Englewood, CO 80112

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (303) 858-8358

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol		Name of exchange on which registered
Common Stock, par value $0.01 per share		GEVO		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 11, 2026, Angelo Amorelli informed the Board of Directors (the “Board”) of Gevo, Inc. (the “Company”) that he will not stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Dr. Amorelli will continue to serve as a member of the Board until the expiration of his term at the Annual Meeting. Dr. Amorelli’s decision to not stand for election at the Annual Meeting is for personal reasons and was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company thanks Dr. Amorelli for his dedicated service and valuable contributions to the Board and the Company during his tenure.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GEVO, INC.
Dated: March 16, 2026	By:	/s/ E. Cabell Massey
		E. Cabell Massey
		Vice President, Legal and Corporate Secretary

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.9 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 33.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 21.8 KB